Search results

Skip to results

Area of interest

Area of interest

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 4711 to 4725 of 7684 results

  1. The committee recommended studies to collect data on the rates of cancelled CT scans, whether cancelled appointments are filled and the effect on patients' experience before and after the introduction of point-of-care (POC) creatinine devices to radiology departments.

    Recommendation ID DG37/3 Question The committee recommended studies to collect data on the rates of cancelled CT scans, whether cancelled

    Research recommendation
    Published
    10 February 2020

  2. What is the effectiveness, cost effectiveness and acceptability of carer passport schemes?

    Recommendation ID NG150/4 Question What is the effectiveness, cost effectiveness and acceptability of carer passport schemes? Any

    Research recommendation
    Published
    10 February 2020

  3. The committee recommended that a suitable risk factor screening tool for identifying risk of PC‑AKI for use across the NHS in people presenting for an outpatient CT scan with contrast agent is developed or an existing tool is validated.

    Recommendation ID DG37/2 Question The committee recommended that a suitable risk factor screening tool for identifying risk of PC‑AKI for

    Research recommendation
    Published
    10 February 2020

  4. Predicting life expectancy:- Is it possible to analyse primary care data to identify characteristics that affect life expectancy and to develop algorithms and prediction tools for patients and healthcare providers to predict reduced life expectancy?

    Recommendation ID NG56/4 Question Predicting life expectancy:- Is it possible to analyse primary care data to identify characteristics

    Research recommendation
    Published
    18 October 2016

  5. Prevention strategies for Charcot arthropathy:- What strategies may be useful in the prevention of Charcot arthropathy?

    Recommendation ID NG19/4 Question Prevention strategies for Charcot arthropathy:- What strategies may be useful in the prevention of Charcot

    Research recommendation
    Published
    12 October 2015

  6. What is the clinical and cost effectiveness of non-selective beta-blockers for the primary prevention of decompensation in people with compensated cirrhosis and signs of clinically significant portal hypertension from non-invasive tests (such as tests to measure liver stiffness, or biomarkers)?

    Recommendation ID NG50/3 Question What is the clinical and cost effectiveness of non-selective beta-blockers for the primary prevention

    Research recommendation
    Published
    11 January 2024

  7. How effective are education-based alcohol prevention interventions (universal or targeted) for children and young people aged 11 to 25 with SEND in full-time education?

    Recommendation ID NG135/5 Question How effective are education-based alcohol prevention interventions (universal or targeted) for children

    Research recommendation
    Published
    25 October 2019

  8. Primary versus secondary stenting for treating people with critical limb ischaemia caused by disease of the infra-geniculate arteries:- What is the clinical and cost effectiveness of selective stent placement compared with angioplasty plus primary stent placement for treating people with critical limb ischaemia caused by disease of the infra-geniculate arteries?

    Recommendation ID CG147/4 Question Primary versus secondary stenting for treating people with critical limb ischaemia caused by disease

    Research recommendation
    Published
    9 June 2015

  9. Priority of treatment for people with anxiety and depression:- For people with both anxiety and depression, which disorder should be treated first to improve their outcomes?

    Recommendation ID CG123/6 Question Priority of treatment for people with anxiety and depression:- For people with both anxiety and depression

    Research recommendation
    Published
    9 June 2015

  10. Probiotic and prebiotic supplements:- What is the clinical and cost effectiveness of probiotics or prebiotics to treat NAFLD in adults, young people and children?

    Recommendation ID NG49/4 Question Probiotic and prebiotic supplements:- What is the clinical and cost effectiveness of probiotics or prebiotics

    Research recommendation
    Published
    24 August 2016

  11. What is the clinical effectiveness of D-dimer and other blood tests and clinical features as prognostic markers of developing post‑COVID‑19 syndrome?

    Recommendation ID NG188/3 Question What is the clinical effectiveness of D-dimer and other blood tests and clinical features as prognostic

    Research recommendation
    Published
    12 November 2021

  12. Prognostic tools:- Is the amyotrophic lateral sclerosis (ALS) Prognostic Index an accurate predictor of survival in people with MND under NHS care in England and/or Wales?

    Recommendation ID NG42/3 Question Prognostic tools:- Is the amyotrophic lateral sclerosis (ALS) Prognostic Index an accurate predictor

    Research recommendation
    Published
    21 March 2016

  13. Promoting a shift to zero- and low-emission travel:- What methods are effective and cost effective at promoting a shift to zero- and low-emission modes of travel, including active travel?

    Recommendation ID NG70/2 Question Promoting a shift to zero- and low-emission travel:- What methods are effective and cost effective at

    Research recommendation
    Published
    12 October 2018

  14. Promoting health and wellbeing:- What is the most effective method for delivering health promotion activities and who should lead them (peers or professionals)?

    Recommendation ID NG57/3 Question Promoting health and wellbeing:- What is the most effective method for delivering health promotion activities

    Research recommendation
    Published
    10 February 2017

  15. Prophylactic antibiotics for preventing exacerbations:- Which subgroups of people with stable COPD who are at high risk of exacerbations are most likely to benefit from prophylactic antibiotics?

    Recommendation ID NG115/5 Question Prophylactic antibiotics for preventing exacerbations:- Which subgroups of people with stable COPD who

    Research recommendation
    Published
    6 February 2019